GlassScriptPhysician profile
Robert I Meyerson
NPI 1295709640
$6,230.62
in general payments reported to CMS, 2019-2025
11 companies · $1,232 in 2025
The $1,232 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $142 · 2021: $1,446 · 2022: $2,450 · 2024: $98.64 · 2025: $1,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,110 · Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,110.18 |
| Food and Beverage | $220.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $3,316.43 | 2022-2025 | |
| Gotham Surgical Solutions & Devices, INC. | $1,994.00 | 2019-2021 | |
| Arthrex, INC. | $268.20 | 2025 | |
| Zimmer Biomet Holdings, INC. | $245.69 | 2021 | |
| Smith+Nephew, INC. | $143.01 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Endo Pharmaceuticals INC. | $124.71 | 2019-2020 | |
| Horizon Therapeutics Plc | $44.00 | 2020 | |
| Ethicon US, LLC | $30.74 | 2025 | Dermabond |
| Integra Lifesciences Corporation | $24.20 | 2019 | |
| Stryker Corporation | $22.69 | 2024 | Mako |
| Acumed LLC | $16.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Meyerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.